iceman's options trading journal

Discussion in 'Journals' started by iceman1, Nov 6, 2005.

  1. APOL

    looks like another decent call - but again I did not do size, yet! Unfortunately I was not in enough long March calls to make much off this position today-- and my Feb 60c is underwater with 5 days to go. I was looking to add next week. I mean --- who would expect APOL to move higher in the midst of a slaughter on NAZ.

    But APOL is up decently today- while the market is going to H in a handbasket. Not bad!

    Suggest we add or get in on any decent PBs This could/might be another NTES home run!
     
    #341     Feb 10, 2006
  2. adding to DNA positions

    managed my long March85 calls by selling Feb85 @1.90-2 and also re-selling Feb 90c (basis = 1.40)

    after previously closing them.

    I now also have a 85p time spread

    + march85
    - feb95p

    -$1

    risk on this --- is DNA being marked back to 80 --- rather than being expiry arbed back to 85 as many like me expect!
     
    #342     Feb 10, 2006
  3. can't wait to start trading pro with HAIRCUT margin later this Q after I pass series 7!

    we are going to produce some great returns.

    this retail options margining is absurd. just can't manage and/or protect yourself enough when things get skewed further than indicated.
     
    #343     Feb 10, 2006
  4. EBAY

    was short 8 EBAY Feb 45p

    was assigned today so now

    +800 EBAY @ (net) 42.50

    (not including all the front month calls - that were sold and closed for ++)


    NB --- over many years my experience with early assignment on (deep) ITM options is that almost 80-85% of the time it marks a bottom (or top) in the underlying security.

    Will keep an eye on EBAY - hard to believe those clowns were able to mark it to 47-48 post-earnings before putting the pedal to the metal! What a scam.

    Suggest going long EBAY ITM calls
     
    #344     Feb 10, 2006


  5. correction


    + march 85p
    - feb 85p
     
    #345     Feb 10, 2006
  6. on Feb 13th closing time for equity and narrow-based index options will change from 402 to 400 ET
     
    #346     Feb 10, 2006
  7. Hmmmmm...

    things that make you go ....

    YEAhh Baaby

    (gordon- you once told me - don't get emotional about stocks - don't...!)
     
    #347     Feb 10, 2006
  8. anyone get into APOL?

    not a bad call !

    IT IS GOING HIGHER guys - be patient and look to enter on PB . Earnings not until mid-March so unless they warn - we could be ready for take-off!

    Recall that my trade target posted on this Journal for APOL is 67-68

    I am sitting here listening to baby boomer bro Steve Tyler singing "Dream ON"

    great tune --

    Sing with me, sing for the years
    Sing for the laughter, sing for the tears
    Sing with me, if it’s just for today
    Maybe tomorrow the good lord will take you away

    I know what nobody knows
    Where it comes and where it goes
    I know it’s everybody’s sin
    You got to lose to know how to win

    Dream on, dream on
    Dream yourself a dream come true
    Dream on, dream on
    Dream until your dream comes true
     
    #348     Feb 10, 2006
  9. 2-10-06

    DNA


    AH news on DNA

    last print 85.25 = +1.75

    Yeahhh Baaabbby :D

    anyone get into DNA before the train leaves the station and it hits 100? :eek:

    It's great to inverst/trade a company that does so much good for people in the real world! Who knows which one of us will actually need a DNA drug --- sometime down the road! Any day they might discover THE wonder drug --- and stock goes to 300!


    Genentech, Biogen: Rituxan OK'd for add'l lymphoma treatment

    SAN FRANCISCO (MarketWatch) -- Genentech Inc. (DNA : genentech inc com new
    News , chart, profile, more
    Last: 83.52+0.01+0.01%

    5:22pm 02/10/2006
    BIIB44.27, +0.03, +0.1%) after Friday's closing bell said the Food and Drug Administration has approved Rituxan for use in the first-line treatment of patients with diffuse large B-cell, CD20-positive, non-Hodgkin's lymphoma in combination with anthracycline-based chemotherapy regimens. Rituxan was discovered by Biogen Idec, and the company co-markets it along with Genentech. Rituxan had previously been approved as a single agent for use in relapsed or refractory, low-grade or follicular, CD20-positive, B-cell non-Hodgkin's lymphoma. The companies said an estimated 360,000 Americans have non-Hodgkins lymphoma, and more than 58,000 new cases are diagnosed annually
     
    #349     Feb 10, 2006
  10. here's what I am going to mediate on this weekend since I messed up a wet dream in AAPl and only did OK by "thinking" that 70 support would have to hold AND by listening to one or more other less experienced traders who claimed AAPl would never fall to 65 -- but rather make new highs soon - and see 100 before 65.

    have a good one!

    iceman1


    “If you really believe in an uncertain outcome, then you also have to expect that virtually anything can happen. Otherwise, the moment you let your mind hold onto the notion that you know, you stop taking all of the unknown variables into consideration. Your mind won’t let you have it both ways. If you believe you know something, the moment is no longer unique.”

    Douglas, Trading in the Zone


    The power of accurate observation is commonly called cynicism... by those who have not got it.

    G. B. Shaw
     
    #350     Feb 10, 2006